Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
113 valent conjugated pneumococcal vaccine----1件: 265 💬
2150 mg GSK1265744B----1件: 265 💬
3300mg Gemcabene1件: Gemcabene---1件: 265 💬
4600mg Gemcabene1件: Gemcabene---1件: 265 💬
5[N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate1件: Acetate---1件: 265 💬
6Abacavir1件: Abacavir2件: Abacavir sulfate ,
Abacavir 💬 		--5件: 2, 49, 135, 265, 325 💬
7Abacavir 300mg twice daily1件: Abacavir2件: Abacavir sulfate ,
Abacavir 💬 		--1件: 265 💬
8Abacavir sulfate1件: Abacavir2件: Abacavir sulfate ,
Abacavir 💬 		--1件: 265 💬
9Abacavir sulfate, Lamivudine and Zidovudine3件: Abacavir,
Lamivudine,
Zidovudine		4件: Lamivudine ,
Zidovudine ,
Abacavir sulfate ,
Abacavir 💬 		--1件: 265 💬
10Acetate1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
11ACETYL- L- CARNITINE----1件: 265 💬
12Acetylcarnitine1件: Acetylcarnitine---3件: 2, 97, 265 💬
13Acipimox1件: Acipimox1件: Acipimox 💬 --2件: 78, 265 💬
14AKCEA-ANGPTL3-LRX----2件: 79, 265 💬
15Amprenavir1件: Amprenavir1件: Amprenavir 💬 --1件: 265 💬
16Antiretroviral/Anti HIV----1件: 265 💬
17Aramchol1件: Aramchol---2件: 94, 265 💬
18Atazanavir1件: Atazanavir2件: Atazanavir sulfate ,
Atazanavir 💬 		--1件: 265 💬
19Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		3件: Ritonavir ,
Atazanavir sulfate ,
Atazanavir 💬 		--1件: 265 💬
20Atazanavir (Reyataz)1件: Atazanavir2件: Atazanavir sulfate ,
Atazanavir 💬 		--1件: 265 💬
21Atazanavir/Ritonavir2件: Atazanavir,
Ritonavir		3件: Ritonavir ,
Atazanavir sulfate ,
Atazanavir 💬 		--1件: 265 💬
22Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬21件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
23ATORVASTATIN CALCIUM2件: Atorvastatin,
Calcium		2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬3件: 79, 97, 265 💬
24ATV----1件: 265 💬
25Avandia administration for 6-12 weeks----1件: 265 💬
26AZT/3TC----1件: 265 💬
27Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬24件: 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
28Behavioral: 60-minutes of steady state exercise----1件: 265 💬
29Behavioral: Diet----2件: 113, 265 💬
30Behavioral: Exercise----6件: 6, 46, 113, 265, 299, 344 💬
31Behavioral: Exercise Training----1件: 265 💬
32Berberine1件: Berberine1件: Coptis rhizome 💬 --3件: 46, 97, 265 💬
33BMS-232632----1件: 265 💬
34Bood and urine sampling----1件: 265 💬
35Caffeine1件: Caffeine2件: Caffeine ,
Caffeine citrate 💬 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 13, 21, 46, 96, 97, 265 💬
36Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
37CD-4 guided therapy interruption----1件: 265 💬
38Cholic Acid1件: Cholic Acid1件: Cholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 20, 234, 265, 310 💬
39Cofactor supplementation (thiamine, riboflavin, L-carnitine)2件: Riboflavin,
Thiamine		4件: Riboflavin ,
Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--1件: 265 💬
40COMBIVIR----1件: 265 💬
41Combivir (zidovudine [AZT] / lamivudine [3TC])2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬 		--1件: 265 💬
42Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----1件: 265 💬
43Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
44Diagnostic Test: Diagnostic Test----1件: 265 💬
45Didanosine1件: Didanosine1件: Didanosine 💬 --2件: 25, 265 💬
46Different HAART regimens----1件: 265 💬
47Diosmin1件: Diosmin1件: Diosmin 💬 --4件: 46, 51, 97, 265 💬
48Diosminex, 500 mg, tabletki powlekane----1件: 265 💬
49Dolutegravir1件: Dolutegravir2件: Dolutegravir ,
Dolutegravir sodium 💬 		--3件: 2, 26, 265 💬
50Dolutegravir / Lamivudine Oral Tablet2件: Dolutegravir,
Lamivudine		3件: Lamivudine ,
Dolutegravir ,
Dolutegravir sodium 💬 		--1件: 265 💬
51Dolutegravir 50 MG1件: Dolutegravir2件: Dolutegravir ,
Dolutegravir sodium 💬 		--1件: 265 💬
52Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]2件: Dolutegravir,
Lamivudine		3件: Lamivudine ,
Dolutegravir ,
Dolutegravir sodium 💬 		--1件: 265 💬
53Doravirine1件: Doravirine1件: Doravirine 💬 --1件: 265 💬
54Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]4件: Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil		6件: Lamivudine ,
Tenofovir disoproxil fumarate ,
Tenofovir ,
Doravirine ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--1件: 265 💬
55Efavirenz1件: Efavirenz1件: Efavirenz 💬 --3件: 23, 67, 265 💬
56Efavirenz (EFV)1件: Efavirenz1件: Efavirenz 💬 --1件: 265 💬
57Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬 --5件: 13, 25, 93, 265, 325 💬
58Emtricitabine/tenofovir2件: Emtricitabine,
Tenofovir		2件: Emtricitabine ,
Tenofovir 💬 		--1件: 265 💬
59Enfuvirtide1件: Enfuvirtide1件: Enfuvirtide 💬 --2件: 25, 265 💬
60Enfuvirtide (T20)1件: Enfuvirtide1件: Enfuvirtide 💬 --1件: 265 💬
61Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
62Gemcabene1件: Gemcabene---2件: 79, 265 💬
63Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----1件: 265 💬
64Genetic: genetic analysis----8件: 34, 85, 90, 93, 94, 96, 234, 265 💬
65Genotropin (human recombinant Growth hormone)----1件: 265 💬
66Growth Hormone----10件: 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
67Growth Hormone Releasing Hormone----1件: 265 💬
68GSK1265744B (sodium salt) containing 14C-GSK1265744B----1件: 265 💬
69High-carbohdyrate breakfast----1件: 265 💬
70High-dose REGN4461----1件: 265 💬
71HIV Anti-retroviral Background Therapy----1件: 265 💬
72Hu Leptin (A-100)1件: Leptin---1件: 265 💬
73Human recombinant leptin (metreleptin)2件: Leptin,
Metreleptin		1件: Metreleptin 💬 1件: LEPR 💬 7件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
74Indinavir1件: Indinavir3件: Indinavir sulfate ,
Indinavir sulfate ethanolate ,
Indinavir 💬 		--1件: 265 💬
75ISIS 304801----1件: 265 💬
76Kaletra (lopinavir [LPVr])1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
77L-Lactic acid2件: L-Lactic acid,
Lactic acid		2件: Lactic acid ,
Sodium lactate 💬 		--1件: 265 💬
78Lactic acid1件: Lactic acid2件: Lactic acid ,
Sodium lactate 💬 		--3件: 46, 265, 299 💬
79Lamivudine1件: Lamivudine1件: Lamivudine 💬 --10件: 2, 26, 42, 46, 49, 135, 156, 223, 265, 325 💬
80Lamivudine/Zidovudine2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬 		--1件: 265 💬
81Leptin1件: Leptin---2件: 6, 265 💬
82Lopinavir1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
83Lopinavir/Ritonavir2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬 		--1件: 265 💬
84Lopinavir/ritonavir + nevirapine3件: Lopinavir,
Nevirapine,
Ritonavir		3件: Ritonavir ,
Nevirapine ,
Lopinavir 💬 		--1件: 265 💬
85Lopinavir/ritonavir + zidovudine + lamivudine4件: Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		4件: Lamivudine ,
Zidovudine ,
Ritonavir ,
Lopinavir 💬 		--1件: 265 💬
86Low-Dose REGN4461----1件: 265 💬
87LY3009104----10件: 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
88Mecasermin1件: Mecasermin2件: Mecasermin ,
Mecasermin rinfabate 💬 		2件: GHR,
IGF1R 💬 		34件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cadherin signaling, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Integrin signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬4件: 96, 168, 265, 299 💬
89Mediterranean Diet----4件: 13, 77, 97, 265 💬
90Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬18件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
91Melatonin supplementation1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 265 💬
92Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬31件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
93METFORMIN HYDROCHLORIDE1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301 💬
94METRELEPTIN1件: Metreleptin1件: Metreleptin 💬 1件: LEPR 💬 7件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
95Metrelpetin----1件: 265 💬
96Mibavademab1件: Mibavademab---1件: 265 💬
97Monotherapy (Lopinavir/ritonavir)2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬 		--1件: 265 💬
98Monotherapy (Lopinavir/ritonavir) + ABC/3TC2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬 		--1件: 265 💬
99Myalept----1件: 265 💬
100Nelfinavir1件: Nelfinavir2件: Nelfinavir mesylate ,
Nelfinavir 💬 		--3件: 49, 265, 331 💬
101Nelfinavir mesylate1件: Nelfinavir2件: Nelfinavir mesylate ,
Nelfinavir 💬 		--1件: 265 💬
102Nevirapine1件: Nevirapine1件: Nevirapine 💬 --1件: 265 💬
103Niacin1件: Niacin1件: Niacin 💬 --4件: 6, 46, 79, 265 💬
104Non-nucleoside reverse transcriptase inhibitors----1件: 265 💬
105Norvir----2件: 265, 299 💬
106NucleomaxX----1件: 265 💬
107Nucleoside analogue sparing HAART regimen----1件: 265 💬
108Nucleoside reverse transcriptase inhibitors----1件: 265 💬
109Obeticholic Acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
110Olumiant----9件: 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
111Other: Biological analysis----1件: 265 💬
112Other: Epicardial adipose tissue measurement on the available tododensitometry used for coronary calcium scoring1件: Calcium---1件: 265 💬
113Other: Glycerine gel----1件: 265 💬
114Other: imaging test----1件: 265 💬
115Other: Observation----1件: 265 💬
116Other: research-specific blood sample----1件: 265 💬
117Other: Standard intervention----1件: 265 💬
118PEGVISOMANT1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 77, 265 💬
119Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265 💬
120Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
121Pioglitazone or metformin2件: Metformin,
Pioglitazone		4件: Metformin hydrochloride ,
Pioglitazone hydrochloride ,
Metformin ,
Pioglitazone 💬 		3件: PPARG,
PRKAA1,
PRKAA2 💬 		28件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Efferocytosis, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 265 💬
122Pneumococcal polysaccharide vaccine 23 valent----1件: 265 💬
123Poly-L-lactic acid2件: L-Lactic acid,
Lactic acid		2件: Lactic acid ,
Sodium lactate 💬 		--1件: 265 💬
124Pravastatin1件: Pravastatin2件: Pravastatin sodium ,
Pravastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬
125Pravastatin sodium1件: Pravastatin2件: Pravastatin sodium ,
Pravastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 265 💬
126Prevenar13----3件: 19, 79, 265 💬
127Protease inhibitor----1件: 265 💬
128Protease inhibitors----1件: 265 💬
129R-metHuLeptin----1件: 265 💬
130Raltegravir1件: Raltegravir2件: Raltegravir ,
Raltegravir potassium 💬 		--4件: 13, 26, 93, 265 💬
131Recombinant human growth hormone----4件: 77, 193, 265, 276 💬
132Recombinant human growth hormone + rosiglitazone1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
133REGN4461----1件: 265 💬
134Reyataz----1件: 265 💬
135REYATAZ 150MG 60 CPS BL----1件: 265 💬
136Riboflavin1件: Riboflavin1件: Riboflavin 💬 --8件: 13, 38, 46, 96, 97, 162, 168, 265 💬
137Ritonavir1件: Ritonavir1件: Ritonavir 💬 --3件: 2, 86, 265 💬
138Ritonavir (Norvir)1件: Ritonavir1件: Ritonavir 💬 --1件: 265 💬
139Rosiglitazone1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬7件: 46, 57, 75, 77, 97, 222, 265 💬
140Rosiglitazone maleate1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265 💬
141RTV----1件: 265 💬
142Saquinavir1件: Saquinavir2件: Saquinavir ,
Saquinavir mesylate 💬 		--4件: 86, 222, 223, 265 💬
143Serostim®[somatropin (rDNA origin) for injection]----1件: 265 💬
144Setmelanotide1件: Setmelanotide2件: Setmelanotide ,
Setmelanotide acetate 💬 		1件: MC4R 💬 3件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 134, 193, 202, 236, 265 💬
145Simvastatin1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬22件: 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
146ST200----1件: 265 💬
147Standard continuous antiretroviral therapy----1件: 265 💬
148Stavudine1件: Stavudine1件: Stavudine 💬 --1件: 265 💬
149SUSTIVA----1件: 265 💬
150TAT4 Gel concentration A----1件: 265 💬
151TAT4 Gel concentration B----1件: 265 💬
152Tenofovir1件: Tenofovir1件: Tenofovir 💬 --8件: 2, 6, 13, 25, 26, 93, 265, 325 💬
153Tenofovir DF1件: Tenofovir1件: Tenofovir 💬 --1件: 265 💬
154Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		4件: Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--3件: 6, 93, 265 💬
155Tenofovir Disoproxil Fumarate2件: Tenofovir,
Tenofovir disoproxil		4件: Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--2件: 6, 265 💬
156Tesamorelin1件: Tesamorelin2件: Tesamorelin ,
Tesamorelin acetate 💬 		1件: GHRHR 💬 3件: Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 265 💬
157Tesamorelin (Egrifta)1件: Tesamorelin2件: Tesamorelin ,
Tesamorelin acetate 💬 		1件: GHRHR 💬 3件: Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 265 💬
158Testosterone1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬9件: 1, 2, 3, 13, 60, 76, 78, 113, 265 💬
159Testosterone injection1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 265 💬
160TH9507----1件: 265 💬
161Thiamine1件: Thiamine3件: Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--5件: 8, 13, 93, 265, 340 💬
162Tipranavir1件: Tipranavir2件: Tipranavir disodium ,
Tipranavir 💬 		--1件: 265 💬
163Tirzepatide1件: Tirzepatide1件: Tirzepatide 💬 2件: GIPR,
GLP1R 💬 		4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 67, 96, 97, 193, 233, 265 💬
164Total Dietary Replacement----1件: 265 💬
165TRUVADA----1件: 265 💬
166Use of lipid-lowering drugs.----1件: 265 💬
167Usual care medications----1件: 265 💬
168Venus Versa----1件: 265 💬
169Viral load driven treatment interruption----1件: 265 💬
170Volanesorsen1件: Volanesorsen2件: Volanesorsen ,
Volanesorsen sodium 💬 		1件: APOC3 💬 2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
171VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide1件: Volanesorsen2件: Volanesorsen ,
Volanesorsen sodium 💬 		1件: APOC3 💬 2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
172Zidovudine1件: Zidovudine1件: Zidovudine 💬 --6件: 25, 26, 135, 265, 325, 331 💬